NLRP3 and colitis: We gavaged high-dose TiO2 NPs daily to NLRP3−/− mice with DSS-induced colitis and found that the absence of NLRP3 improved the anti-oxidative ability of the liver (Figure 5a–c), which was manifested by a decreased MDA content, enhanced SOD activity, and increased GSH content.